The Pursuit of Immortality Meets Reality: Biohacker Bryan Johnson Battles Autoimmune Gastritis

In a surprising turn of events for a man who has dedicated his fortune to the science of biological immortality, American tech entrepreneur Bryan Johnson has announced that he is battling autoimmune gastritis. Johnson, 48, has become a polarizing figure in the wellness community due to his 'Don't Die' philosophy, a lifestyle characterized by an obsessive pursuit of longevity that costs him approximately $2 million per year.
According to a recent social media update, the diagnosis came after months of rigorous medical scrutiny. Johnson had noticed a persistent deficiency in iron, which prompted a deep dive into his internal health. By May, the results confirmed that his immune system was attacking the mucosal lining of his own stomach—a condition metaphorically described by Johnson as his stomach "eating itself."
Autoimmune gastritis is a chronic condition where the body's defense mechanisms mistakenly target the gastric mucosa. This process often impairs the body's ability to absorb critical nutrients, most notably Vitamin B12 and iron. Medical literature suggests that if left untreated, the condition can significantly elevate the risk of developing stomach cancer. While it is estimated to affect between 0.5% and 4.5% of the adult population globally, the disease is notoriously difficult to detect in its early stages, as symptoms like bloating, abdominal pain, and heartburn are frequently dismissed as common indigestion.
Reflecting on the origins of the illness, Johnson pointed to a period of his life that stands in stark contrast to his current disciplined regime. He recalled a youth filled with sugary cereals, sodas, and fast food. As he entered the high-pressure world of entrepreneurship and fatherhood, the combination of chronic stress and a poor diet led to a significant decline in his health, including a weight gain of roughly 18 kilograms and severe chronic depression. Johnson believes that this period of instability triggered the autoimmune responses that first targeted his thyroid and subsequently migrated to his gastric lining.
For most patients, autoimmune gastritis is viewed as a manageable condition rather than a curable one. Standard medical practice focuses on supplementation and long-term monitoring to prevent complications. However, Johnson—supported by a private team of over 30 physicians—is not content with mere management. He has expressed a desire to completely "reset" the problematic immune cells. His proposed strategy involves cutting-edge, experimental interventions, including the use of AI-designed antibodies to precisely target and neutralize the cells attacking his stomach.
While Johnson's ambition is vast, medical experts have voiced caution. He admits that these proposed treatments currently lack robust clinical validation and are supported primarily by pre-clinical research. Some specialists, including autoimmune expert Dr. Janoska, suggest that the relentless pursuit of "perfect health" through constant monitoring and biohacking may actually exert a detrimental level of long-term stress on the human body. Others, such as Dr. Campbell, emphasize that emotional and psychological well-being are just as critical as biological markers in the journey toward true health.
Despite these warnings, Johnson remains committed to his path. Having already experimented with plasma exchanges involving his son and various gene therapies, he views this latest diagnosis as another data point to be solved. He has pledged to document his treatment process transparently, offering the world a front-row seat to his attempt to reprogram his own immune system.